As public health officials deal with a second wave of the novel H1N1 influenza virus, new information is available on the health consequences of exposure to such airborne infectious diseases and the implications on the design, installation and operation of HVAC&R systems.
“While the long-standing public health view is that influenza transmission occurs through direct contact or large droplets, newer data suggests it also occurs through the airborne route, meaning HVAC&R systems may contribute far more to transmission of the disease and, potentially, to reduction of that same transmission risk,” says Gordon Holness, president of the American Society of Heating, Refrigerating and Air-Conditioning Engineering (ASHRAE) that developed the guidance.
ASHRAE’s Airborne Infectious Diseases Position Document addresses the impact of ventilation on disease transmission, the disease for which ventilation is important for either transmission or control and the control strategies that are available for implementation in buildings. The paper can be accessed at www.ashrae.org/positiondocuments.
Since the first reported case in the spring of 2009, the novel H1N1 influenza virus has spread to nearly 170 countries, resulting in 1,154 deaths and some 160,000 illnesses. With a better understanding of ventilation’s effect on the transmission of disease, future incidents of the H1N1 virus may now be easier to prevent, according to Holness. He said several technical solutions are available to assist in avoiding transmission. These include: dilution ventilation, airflow strategies, room pressurization, personalized ventilation, source control, filtration and ultraviolet germicidal irradiation.
Airborne transmission through building ventilation systems can be significantly reduced by provision of adequate air filtration and pressurization, Holness said. ASHRAE’s other guidance of relevance includes Standard 170, Ventilation of Health Care Facilities.
Unraveling a Candida auris Outbreak: Infection Control Challenges in a Burn ICU
March 19th 2025A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.
Unmasking Long COVID: Dr Noah Greenspan on Recovery, Research Gaps, and the Future of Treatment
March 18th 2025Dr Noah Greenspan discusses the evolving understanding of long COVID, current treatment strategies, diagnostic challenges, and the critical need for research and awareness in post-viral syndromes.